Navigation Links
Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076
Date:5/6/2013

ROCKVILLE, Md., May 6, 2013 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual Property Office of Patent Certificate No. ZL 200680044656.7.  The granted claims are directed to ENMD-2076, covering composition of matter and uses to treat various cancers.  The patent is part of EntreMed's broad intellectual property portfolio for ENMD-2076.

(Logo:  http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

"We are very pleased with the issuance of this patent in China for ENMD-2076," said Ken K. Ren , Ph.D., the Company's Chief Executive Officer.  "This patent provides intellectual property protection for ENMD-2076 in a market that is experiencing tremendous growth and of which we intend to capitalize on.  The issuance of this patent broadens our existing international patent estate for ENMD-2076 and also confirms the Chinese State Intellectual Property Office's recognition that ENMD-2076 represents new and inventive chemical structures." 

ENMD-2076 has completed and shown activity in Phase 1 clinical trials in solid tumor cancers, leukemia, multiple myeloma, and is completing a Phase 2 trial for ovarian cancer.  A Phase 2 triple-negative breast cancer trial at the University of Colorado and Indiana University and a Phase 2 trial in advanced/soft tissue sarcoma at Princess Margaret Hospital are currently enrolling.  As part of its global development strategy utilizing China resources, EntreMed has submitted a new drug clinical trial application with the Chinese Food and Drug A
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
2. Patent Issued In U.S. For EntreMeds 2ME2 In Rheumatoid Diseases
3. Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
4. Dr. Isaac Eliaz Awarded Patent for Modified Citrus Pectin and Alginates
5. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
6. LamdaGen Corporation Issued United States Patent for Diagnostics on Plasmonic-Based Nanosensors
7. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
8. Bioinformatics Market: Technologies, Patenting Trends & 2017 Forecasts
9. Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis
10. VolitionRx Files Two Patent Applications
11. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between dropping ... health was forgotten. But Audicus , a next-generation ... better this new year. Hearing loss is ... aging population, though it is often unaddressed. Forty-eight million ... has a hearing aid, mainly due to price. Hearing ...
(Date:12/19/2014)... Dec. 18, 2014  Decision Resources Group finds that ... States will increase to a value of ... driven by expansion in the large direct energy device ... be increasingly adopted due to the advantages they offer ... key findings from Decision Resources Group,s coverage of the ...
(Date:12/19/2014)... Baptist Health Lexington is the first facility in ... Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status from the ... is the most common cardiac arrhythmia and has become recognized ... to stroke and possible death. More than 5 million patients ... fibrillation and the numbers are rapidly increasing as the population ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... A novel combination of drugs was,able to completely ... promise for the effective treatment of patients with ... Illinois University,School of Medicine presented the results of ... and pulmonary metastases in female SCID,mice., Paclitaxel ...
... in Breast Cancer -, SAN ANTONIO ... PTC,Therapeutics, Inc. (PTC), a biopharmaceutical company focused ... drugs,targeting post-transcriptional control mechanisms announced the,presentation of ... its novel,internally discovered, vascular endothelial growth factor ...
Cached Medicine Technology:New Drug Combination is Able to Eradicate Breast Metastases in Mice 2PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 2PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 3PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 4
(Date:12/17/2014)... Dr. Myo Nwe is the co-author of ... the Future” and co-founder of the Ace Medical Weight Loss ... takes a broad look at the industry of weight loss, ... scrutiny. On film and in television shows, however, she says ... social aspects and played for basic laughs, which she believes ...
(Date:12/17/2014)... HeartMath® Inc., recognized as one of the ... (HRV), heart coherence and the physiology of emotions, ... algorithms to chipset manufacturers and consumer electronics companies. ... offer its HRV solutions, tap into its HRV ... normative HRV databases and algorithms for developing consumer ...
(Date:12/17/2014)... No matter how far modern medicine advances, ... head louse parasite—a common childhood malady and a source ... six and twelve million individuals will suffer an infestation. ... company comes to the rescue, providing an all-natural treatment ... track record of customer service, and effectiveness in getting ...
(Date:12/17/2014)... MONDAY, Dec. 15, 2014 (HealthDay News) -- As gas ... and deaths, a new study suggests. In times ... many of those riders are inexperienced, the researchers explained. ... in California, which has the highest number of motorcycle ... number of motorcyclist deaths. The analysis revealed a ...
(Date:12/17/2014)... Dec. 16, 2014 (HealthDay News) -- Poor students get more ... a new study finds. But, the opposite is true ... having fruits and vegetables at school may give a healthy ... But, no matter what the family income level, students all ... the study found. The study was published recently in ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2
... ... on collaboration - has released a case study about how its innovative HR transformation process ... strategic role, including developing HR leaders. , ... Cambridge, MA (PRWEB) June 23, 2009 -- Interaction Associates (IA) - a 40-year ...
... ... launched his new website, www.LivingwellNewYork.com , to coincide with an exciting new direction he is ... ... has been practicing Chiropractic care in New York City for more than 13 years in ...
... ... technology company, and FIND (Foundation for Innovative New Diagnostics), a Swiss foundation that develops, ... a significant price reduction in the cost of liquid culture testing for TB (Tuberculosis). ... Oxford, UK ...
... , MELBOURNE, Australia, June 22 Cytopia Ltd (ASX: CYT) ... Application (IND) with the US Food and Drug Administration (FDA) ... , , Following FDA review, the company intends to ... myelofibrosis, a serious progressive and chronic condition where scar tissue ...
... Stroke Company Exemplifies Firm,s Strategy in the Field of ... 22 Sofinnova Partners of Paris, France today announced ... device company CoAxia. The round also included participation ... Partners, Canaan Ventures Partners, Johnson and Johnson Development Corporation, ...
... PHILADELPHIA, June 22 With yet another tragedy in ... strong regulations to protect residents of our state,s assisted ... outrageous and dangerous practices such as those that forced ... Brightfield assisted living facility. , , Earlier this ...
Cached Medicine News:Health News:Transforming the HR Function Into Strategic Partner at World's Largest Medical Device Company 2Health News:New York City Chiropractor Announces New State-Of-The-Art Facility, Website 2Health News:BD and FIND Achieve Milestone in Global Battle Against MDR-TB 2Health News:BD and FIND Achieve Milestone in Global Battle Against MDR-TB 3Health News:BD and FIND Achieve Milestone in Global Battle Against MDR-TB 4Health News:Cytopia Lodges IND for JAK2 Inhibitor CYT387 2Health News:Sofinnova Partners Leads Investment Round in CoAxia 2Health News:Sofinnova Partners Leads Investment Round in CoAxia 3Health News:Death at Assisted Living Facility Points to Desperate Need for Better Regulations from the State 2Health News:Death at Assisted Living Facility Points to Desperate Need for Better Regulations from the State 3
Knife sharpening kit...
... work, it is necessary to cool a specimen ... be fitted to most microtomes and will permit ... depending on conditions. The equipment consists of a ... stage is best suited for operation with a ...
... MNL 4404 & 4405 series Freezing Stages ... devices have no moving parts and need only ... water for operation. Freezing starts immediately ... is adjustable so that optimum cutting temperatures can ...
... The autoimmune destruction of the insulin-producing ... a period of time leading to ... mellitus. During this extended pre-clinical phase, ... a variety of islet cell antigens ...
Medicine Products: